LSBio
IHC-plus™ ADGRL4 / ELTD1 Antibody (230-310 aa, Internal)

Human Heart: Formalin-Fixed, Paraffin-Embedded (FFPE), at a concentration of 5 ug/ml.

IHC-plus™ ADGRL4 / ELTD1 Antibody (230-310 aa, Internal)

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Enzyme-Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Human
Format:Liquid
See all ADGRL4 / ELTD1 antibodies →
$470.00each
Catalog Number: LS-B15548-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
ELTD1 antibody LS-B15548 is an unconjugated rabbit polyclonal antibody to human ELTD1 (ADGRL4) (230-310 aa, Internal). Validated for ELISA, IF, IHC and WB. Tested on 20 paraffin-embedded human tissues. Cited in 1 publication.
Application
ELISA, IF, IHC, IHC-P, WB
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This product carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
ELTD1 | ETL | ETL protein | KPG_003
Recommended Dilution: ELISA
1:20000
Recommended Dilution: IF/ICC
1:200 - 1:1000
Recommended Dilution: IHC-P
5 µg/ml
Recommended Dilution: WB
1:500 - 1:2000
UniProt Number
Q9HBW9
SwissProt
Q9HBW9

Target

Target
ADGRL4 / ELTD1
Antigen Species
Human
Specificity
ETL Polyclonal Antibody detects endogenous levels of ETL protein.
Epitope
ETL Polyclonal Antibody detects endogenous levels of ETL protein.
Gene Name
ADGRL4

Antibody

Host Species
Rabbit
Clonality
Polyclonal
Origin Species
Human

Immunogen

Immunogen
Synthesized peptide derived from human ETL

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
Concentration
1 mg/mL
Animal Free
No
Carrier-Free
No
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store at -20°C. Avoid freeze-thaw cycles.
Recommended Storage Buffer
PBS
ELTD1 Promotes Gastric Cancer Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through MAPK/ERK Signaling by Regulating CSK. Bo Sun, Fang-Jing Zhong. International journal of general medicine. 2021 Aug;14:4897-4911. PubMed: 34475781 PMC: PMC8407680

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.